In July, hope was expressed on this page about new developments in the accessibility of clinical trial data. Several leading medical journals had pressed for a requirement that all clinical trials be placed in a public registry, a proposal endorsed by the American Medical Association (AMA) and the Association of American Medical Colleges. The AMA had urged the institutional review boards (IRBs) that review trial protocols to require such registration before approval of a drug. The World Health Organization further supports an international registry.
No takes yet. Share an insight, caveat, or question.
Donald Kennedy (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: